Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
1.95
Dollar change
-0.05
Percentage change
-2.50
%
Index- P/E- EPS (ttm)-0.95 Insider Own3.56% Shs Outstand67.75M Perf Week-3.47%
Market Cap132.11M Forward P/E- EPS next Y-0.93 Insider Trans1.19% Shs Float65.34M Perf Month2.63%
Income-50.39M PEG- EPS next Q-0.24 Inst Own60.45% Short Float0.44% Perf Quarter32.65%
Sales0.35M P/S377.46 EPS this Y-0.43% Inst Trans0.61% Short Ratio0.53 Perf Half Y18.90%
Book/sh1.43 P/B1.36 EPS next Y1.91% ROA-46.26% Short Interest0.29M Perf Year-9.72%
Cash/sh1.45 P/C1.35 EPS next 5Y13.00% ROE-62.16% 52W Range1.08 - 2.70 Perf YTD38.30%
Dividend Est.- P/FCF- EPS past 5Y43.36% ROI-48.25% 52W High-27.78% Beta1.25
Dividend TTM- Quick Ratio6.27 Sales past 5Y436.18% Gross Margin-676.49% 52W Low80.54% ATR (14)0.14
Dividend Ex-Date- Current Ratio6.27 EPS Y/Y TTM40.37% Oper. Margin-15557.79% RSI (14)56.50 Volatility6.54% 7.47%
Employees59 Debt/Eq0.17 Sales Y/Y TTM-96.60% Profit Margin-14274.50% Recom1.00 Target Price22.60
Option/ShortYes / Yes LT Debt/Eq0.15 EPS Q/Q3.56% Payout- Rel Volume1.34 Prev Close2.00
Sales Surprise-100.00% EPS Surprise-5.04% Sales Q/Q-100.00% EarningsMar 14 AMC Avg Volume542.73K Price1.95
SMA206.91% SMA509.57% SMA20017.17% Trades Volume725,894 Change-2.50%
Date Action Analyst Rating Change Price Target Change
Jul-05-23Downgrade Oppenheimer Outperform → Perform
Oct-12-21Initiated RBC Capital Mkts Outperform $22
Sep-21-21Initiated Piper Sandler Overweight $19
May-10-21Initiated Laidlaw Buy $18
Aug-17-20Upgrade H.C. Wainwright Neutral → Buy $13
Mar-04-20Initiated ROTH Capital Buy $15
Mar-02-20Initiated Oppenheimer Outperform $8
Feb-14-18Downgrade JP Morgan Neutral → Underweight
Sep-07-17Initiated Piper Jaffray Overweight $7
Dec-13-16Downgrade JP Morgan Overweight → Neutral
Mar-15-24 01:33PM
11:30AM
11:01AM
Mar-14-24 08:56PM
04:16PM
04:00PM Loading…
04:00PM
Feb-28-24 08:00AM
Feb-21-24 08:00AM
Jan-29-24 08:00AM
Jan-18-24 08:00AM
Nov-13-23 08:00AM
Nov-09-23 04:07PM
04:00PM
Nov-01-23 08:00AM
Oct-31-23 08:00AM
08:00AM Loading…
Sep-11-23 08:00AM
Aug-30-23 09:35AM
Aug-24-23 08:00AM
Aug-09-23 05:30PM
04:29PM
04:00PM
Jul-20-23 07:30AM
Jun-28-23 07:00AM
Jun-22-23 08:00AM
Jun-20-23 08:00AM
Jun-09-23 04:00PM
Jun-06-23 08:00AM
May-25-23 08:00AM
May-22-23 08:00AM
07:33AM
08:06AM Loading…
May-13-23 08:06AM
May-11-23 04:00PM
May-10-23 06:11AM
May-09-23 05:15PM
04:12PM
04:00PM
May-07-23 04:00AM
May-05-23 02:24PM
Apr-17-23 08:00AM
Mar-30-23 08:00AM
Mar-28-23 10:45AM
Mar-23-23 07:10AM
Mar-21-23 08:00AM
Mar-20-23 08:00AM
Mar-09-23 05:15PM
04:00PM
Mar-08-23 08:00AM
Mar-02-23 08:00AM
Mar-01-23 08:00AM
Feb-17-23 12:00PM
Feb-10-23 05:21AM
Feb-09-23 08:00AM
Feb-08-23 04:11PM
Feb-06-23 08:00AM
Jan-31-23 08:00AM
Jan-19-23 08:00AM
Jan-18-23 08:00AM
Dec-29-22 06:59PM
Dec-15-22 08:00AM
Nov-18-22 04:00PM
Nov-10-22 05:15PM
04:00PM
08:00AM
Nov-09-22 08:00AM
Nov-03-22 08:02AM
Oct-25-22 08:00AM
Oct-11-22 08:00AM
Oct-04-22 08:00AM
Sep-29-22 08:00AM
Sep-27-22 08:00AM
Sep-16-22 08:35AM
Sep-13-22 08:00AM
Sep-12-22 08:35AM
Sep-09-22 11:52AM
08:00AM
Sep-06-22 08:00AM
Sep-01-22 08:00AM
Aug-15-22 04:00PM
Aug-12-22 04:05PM
Aug-11-22 08:03AM
Aug-04-22 08:00AM
Jun-24-22 02:22PM
Jun-14-22 08:00AM
Jun-13-22 08:00AM
Jun-01-22 08:00AM
May-17-22 08:00AM
May-16-22 08:00AM
May-13-22 04:00PM
May-10-22 02:00PM
08:00AM
May-09-22 05:15PM
04:00PM
02:40AM
May-02-22 08:00AM
Apr-14-22 12:14PM
Apr-13-22 08:00AM
Apr-11-22 08:00AM
Apr-06-22 09:55AM
Apr-02-22 03:25PM
Apr-01-22 11:45AM
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Broadfoot Jill MarieChief Financial OfficerFeb 06 '24Sale1.691,5902,68720,821Feb 06 08:18 PM
Shukla SanjayPresident and CEODec 12 '23Buy1.1812,00014,136106,173Dec 12 06:50 PM
Shukla SanjayPresident and CEODec 11 '23Buy1.173,0003,51094,173Dec 12 06:50 PM
Shukla SanjayPresident and CEONov 13 '23Buy1.1113,57815,08591,173Nov 13 04:11 PM
Shukla SanjayPresident and CEONov 10 '23Buy1.141,4221,61877,595Nov 13 04:11 PM
Shukla SanjayPresident and CEOJul 28 '23Buy2.0115,00030,22476,173Aug 01 04:07 PM
SCHIMMEL PAULDirectorMay 10 '23Buy2.25200,000450,000313,023May 11 09:00 AM